Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6451–6500 of 18646
On February 22, 2024, American Homes 4 Rent (the “Company”) announced that David P. Singelyn, the Company’s Chief Executive Officer, had notified the Board of Trustees (the “Board”) of the Company of his intent to retire.
the Board had appointed Bryan Smith, the Company’s Chief Operating Officer, as the new Chief Executive Officer of the Company, effective upon Mr. Singelyn’s retirement
On February 20, 2024 (the “Separation Date”), Salarius Pharmaceuticals, Inc. (the “Company”) entered into a separation and release agreement (the “Separation Agreement”) with David J. Arthur, the Company’s President and Chief Executive Officer, which provides for Mr. Arthur’s separation of employment, effective as of the Separation Date.
In July 2020, Mr. Forelle was appointed interim consulting CEO reporting to the board.
Effective February 26, 2024, P. Cameron Hyzer, who has served as ZoomInfo’s Chief Financial Officer since 2018, will assume the additional role of principal accounting officer.
On February 19, 2024, Mark W. Smith informed Helmerich & Payne, Inc. (the “Company”) that he will retire from his position as Senior Vice President and Chief Financial Officer of the Company effective August 15, 2024 or such earlier date as agreed to with the Company (the “Transition Date”).
Nishan J. Vartanian’s announcement to the Board on February 21, 2024, of his intention to retire as Chief Executive Officer in May 2024.
On February 21, 2024, the Board of Directors (the “Board”) of MSA Safety Incorporated (the “Company”) elected Steven C. Blanco as Chief Executive Officer, to be effective May 10, 2024.
On February 19, 2024, Gain Therapeutics, Inc. (the “Company”) received notice of the resignation of C. Evan Ballantyne as the Company’s Chief Financial Officer, and all other positions held at the Company, to be effective March 1, 2024.
Ms. Lessinger succeeds Nick Bailey, President and CEO of RE/MAX, who is leaving RE/MAX and the Company.
As of the Effective Date, Mr. Pitigoi will be replacing Michael Ellis as the Chief Financial Officer of Flywire.
On February 22, 2024, Flywire Corporation (“Flywire”) announced that Cosmin Pitigoi will join Flywire as Chief Financial Officer and as its principal financial and principal accounting officer, effective March 4, 2024
On February 21, 2024, Robert Noreck, the Company's Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer (collectively, “CFO”), notified the Company of his intent to resign as CFO, effective as of the earlier of May 31, 2024 and the appointment of a successor CFO (such date, the “Transition Date”).
Synlogic, Inc. (the “ Company ”) and Aoife Brennan, M.B., Ch.B., President and Chief Executive Officer, agreed that Dr. Brennan’s employment with the Company will terminate effective March 9, 2024
Khairul Azmi Bin Ismaon , age 41, serves as our Chief Executive Officer and one of our directors.
Dr. Ulf Henning Richter , age 44, serves as our Chief Financial Officer.
Jian-Meng Yang was appointed as Chief Executive Officer, Treasurer and Secretary, and Director of the Company.
announced Michael G. Rippey's retirement as Chief Executive Officer (“ CEO ”) and his resignation from the Company's Board of Directors (the “ Board ”), effective May 15, 2024.
The Company also announced that current President, Katherine T. Gates, will succeed Mr. Rippey as CEO, effective upon his retirement.
On February 22, 2024, the Company announced that Jason Alger, age 40, the Company’s Chief Accounting Officer and principal accounting officer, will assume the role of Chief Financial Officer and principal financial officer of the Company, effective March 1, 2024.
On February 16, 2024, Bryan Hunt informed the board of directors of the Company (the Board) of, and on February 20, 2024, the Board accepted, his resignation as the Company's Chief Financial Officer and principal financial officer, effective March 1, 2024.
Tom Fitzgerald notified the Company of his decision to retire as the Company’s Chief Financial Officer (“CFO”), effective as of September 1, 2024.
On February 19, 2024, Tom Fitzgerald notified the Company of his decision to retire as the Company’s Chief Financial Officer (“CFO”), effective as of September 1, 2024.
Mr. Trepp, who, prior to the Effective Date, served as President and Chief Executive Officer of the Company, will continue to serve as Chief Executive Officer of the Company after the Effective Date.
On February 18, 2024, Timothy F. Murphy, Senior Vice President and Chief Financial Officer, informed the Company of his plans to retire in early 2025.
Michael McMullen, President and Chief Executive Officer (“CEO”) of Agilent Technologies, Inc. (the “Company” or “Agilent”), notified the Company that he will retire as President and CEO of the Company and as a member of the Company’s Board of Directors (“Board”) on May 1, 2024.
Mr. Teno will succeed David Willetts, who resigned as President and Chief Executive Officer of the Company and as a member of the Board, effective on the Effective Date.
On February 21, 2024, the Company announced the appointment of Andrew J. Teno as President and Chief Executive Officer of the Company and of Icahn Enterprises G.P. Inc. (“Icahn Enterprises GP”), the general partner of the Company and Icahn Enterprises Holdings L.P., effective as of February 21, 2024 (the “Effective Date”).
On February 20, 2024, Glendon E. French resigned as President and Chief Executive Officer of Pulmonx Corporation (the “Company”), effective as of March 15, 2024
On February 19, 2024, the Company’s board of directors appointed Steven S. Williamson as the Company’s President and Chief Executive Officer and a Class II member of the board of directors, each as of the Effective Date.
On February 21, 2024, Jazz Pharmaceuticals plc (the “Company”) announced the appointment of Philip Johnson as the Company’s Executive Vice President and Chief Financial Officer, effective as of March 1, 2024.
appointed Benjamin L. Schmitt to serve as the Bancorp’s and Bank’s permanent Senior Vice President, Chief Financial Officer and Treasurer, effective February 20, 2024.
appointed Joseph C. Papa as President and CEO of the Company, effective February 21, 2024.
Haywood Miller, who will step down from his role as interim CEO of the Company, effective February 21, 2024.
On February 21, 2024, Joshua Ballard, Chief Financial Officer of Energy Recovery, Inc., (the “Company”) announced that he intended to resign as Chief Financial Officer effective on June 30, 2024.
On February 15, 2024, Steve Buhaly resigned from his position as the Chief Financial Officer of BioSig Technologies, Inc. (the “ Company ”), effective as of the same date.
On February 21, 2024, The RealReal, Inc. (the “Company”) announced that Ajay Gopal has been appointed by the Board of Directors (the “Board”) of the Company to serve as the Company’s Chief Financial Officer, effective March 18, 2024
Joining the Company effective March 1, 2024, in the role of Executive Vice President and Chief Financial Officer is Mr. Galagher Jeff,
Ashish Sharma resigned as Chief Executive Officer and President of the Company, to be effective as of February 23, 2024.
Mr. Jones will be succeeded as CEO by Mark Miller (such succession, the “CEO Succession”).
On February 14, 2024, the board of directors (the “Board”) of Nikola Corporation (the “Company”) appointed Stephen J. Girsky, the Company’s President and Chief Executive Officer, as the Company’s Acting Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.
It is expected that Don Cummings, the Company’s current Senior Vice President, Chief Accounting Officer and Controller will be appointed Chief Financial Officer as of June 3, 2024.
Marcia Wadsten notified the Company of her intention to retire as Executive Vice President and Chief Financial Officer as of June 3, 2024.
the Board also appointed Michael S. Iskra to serve as the Company’s Interim Chief Executive Officer and Robert J. Bujarski to serve as the Company’s Interim President, each effective February 21, 2024.
On February 14, 2024, the Board of Directors (the “Board”) of QuidelOrtho Corporation (the “Company”) determined to terminate Douglas C. Bryant, the Company’s President and Chief Executive Officer, effective February 21, 2024.
that the Board of Directors of Olin (the “Board”) has appointed Kenneth Lane, 55, as President and Chief Executive Officer of Olin, effective as of March 18, 2024
Scott M. Sutton, who will be stepping down as President and Chief Executive Officer and Director of Olin on the Effective Date.
Bruce K. Lee, the Company’s President and Chief Executive Officer (“CEO”), and a member of the Board of Directors (the “Board”), informed the Board that he intends to retire by the end of 2024.
On the Effective Date, Florence Neubauer will no longer serve as Interim Chief Financial Officer of the Company.
it had appointed Girish Satya, to serve as the Company’s Chief Financial Officer with an effective date of February 21, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.